Adcetris (brentuximab vedotin) - Takeda, Pfizer
https://programme.conventus.de/ado-2026/program/program-points/af49ecf6-9f72-447f-8837-22c323294ec7
 
Dr. Mathias Oymanns
 
Sep 7, 2026
 
Prev Next